Tick-borne encephalitis virus triggers inositol-requiring enzyme 1 (IRE1) and transcription factor 6 (ATF6) pathways of unfolded protein response  by Yu, Chao et al.
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a  b  s  t  r  a  c  t
Tick-borne  encephalitis  (TBE)  is  a  serious  human  neurological  disease  caused  by  TBE virus  (TBEV).  How-
ever, the  mechanisms  of TBEV-caused  pathogenesis  remain  unclear.  The  endoplasmic  reticulum  (ER)
stress  response,  also  deﬁned  as the unfolded  protein  response  (UPR),  is an  important  conserved  molec-
ular  signaling  pathway  that modulates  many  biological  functions  including  innate  immunity  and  viral
pathogenesis.  Here,  we  investigated  the  effects  of the  two  UPR  signaling  pathways  upon TBEV  infec-
tion  in  Vero  E6 cells.  We  showed  that  the   of heat shock protein 72 (Hsp72) increased in the
course  of TBEV  infection.  We  then  conﬁrmed  that TBEV  infection  activates  the  IRE1  pathway,  leading  to
RNA and  protein  expression  of  the  spliced  X box  binding  protein  1 (sXBP1).  Furthermore,  we  observed
tamountR stress
BP1
TF6
irus replication
the  translocation  of ATF6  during  TBEV  infection  and  expression  of  cleaved  transcription  factor  6  (ATF6)
which  suggest  activation  of  ATF6  pathway.  Finally,  we examined  whether  inhibition  of the  IRE1 pathway
has  an  effect  on  TBEV  infection.  Cell  treatment  with  3,5-Dibromosalicylaldehyde  (IRE1  inhibitor)  and
tauroursodeoxycholic  acid  (TUDCA)  showed  that TBEV  replication  was  signiﬁcantly  limited.  These ﬁnd-
ings  provide  the  ﬁrst evidence  that  TBEV  infection  activates  the  two  UPR  signaling  pathways.  Moreover,
inhibition  of  TBEV  replication  by  UPR  inhibitors  may  provide  a novel  therapeutic  strategy  against  TBE.
© 20  . Introduction
Tick-borne encephalitis virus, within the genus Flavivirus of the
amily Flaviviridae, is an emerging zoonotic virus transmitted by
icks in Europe, the Far East and Asia (Gritsun et al., 2003; Mansﬁeld
t al., 2009). It can cause severe infection in humans with a variety
f neurological symptoms and diseases (Lindquist and Vapalahti,
008). In recent years, thousands of diagnosed TBE cases were
eported annually, although TBEV infection can be efﬁciently pre-
ented by vaccination (Demicheli et al., 2009; Donoso Mantke et al.,
011; Suss, 2008). The genome of TBEV consists of a single-stranded
ositive-sense RNA of about 11 kb in length. It has a single open
eading frame which translates for a polyprotein consisting of three
tructural proteins (C, prM and E) and seven non-structural proteins
NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) (Heinz and Allison,
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2003). Translation, secretion and modiﬁcation of the viral proteins
as well as virus RNA replication and virus assembly take place at the
membranes of the endoplasmic reticulum (ER) and Golgi-derived
membranes called vesicle packets (VP). Therefore, TBEV and other
ﬂaviviruses modify the ER architecture, resulting in membrane pro-
liferation and hypertrophy of ER, which is beneﬁcial for ﬂavivirus
protein secretion and modiﬁcation (Fernandez-Garcia et al., 2009;
Gillespie et al., 2010). Furthermore, reorganized ER protects and
maintains newly replicated RNA for the step of virus replication
(Miorin et al., 2013).
ER stress is one of the most important cellular reactions caused
by virus infection due to high amounts of viral proteins in the ER
(He, 2006). The cell reacts to ER stress by activating the unfolded
protein response (UPR) pathway which removes misfolded pro-
teins either by attenuating general translation or by enhancing ER
folding capacity and ER-associated degradation (Lin et al., 2008).
In the ER stress situation, the UPR signaling pathway is medi-
ated by three major transmembrane ER-resident proteins, namely
protein kinase RNA-like ER kinase (PERK), activating transcription
Open access under CC BY-NC-ND license.factor 6 (ATF6) and inositol-requiring enzyme 1 (IRE1) (Ron and
Walter, 2007). In the PERK pathway, PERK phosphorylates eukary-
otic translation initiation factor 2 (eIF2), resulting in a decline
of protein synthesis (Harding et al., 1999). Activation of the ATF6
icense. 
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athway generates an active ATF6 fragment which translocates to
he nucleus and up-regulates transcription of UPR genes (Ye et al.,
000). The IRE1 pathway is initiated by IRE1 and controlled by a
eries of regulators termed as the UPRosome. The UPRosome con-
ists of a complex protein assembled at the ER membrane, such as
eat shock protein 72 (Hsp72), apoptosis signal-regulating kinase 1
ASK1)-interacting protein 1 and the pro-apoptotic proteins Bcl-2-
ssociated X protein (BAX) and Bcl-2 homologous antagonist/killer
BAK) (Hetz, 2012). However, modulation of the IRE1 pathway
ignaling by these regulators, which associate or dissociate with
RE1, is cell type dependent. Upon activation of the IRE1 pathway,
ctive IRE1 processes the X box binding protein 1 (XBP1) mRNA by
hifting the open reading frame. This results in the expression of
he active transcription factor spliced XBP1 (sXBP1), which then
p-regulates its target genes (Yoshida et al., 2001).
Recent studies have shown that several ﬂaviviruses preferen-
ially use different UPR pathways to facilitate their replication.
tudies with Japanese encephalitis virus (JEV) and Dengue virus
DENV) have shown activation of the IRE1 pathway during infec-
ion (Umareddy et al., 2007; Yu et al., 2006). West Nile virus (WNV)
odulates all three pathways of the UPR which results in up-
egulation of the production of viral RNA and protein (Ambrose
nd Mackenzie, 2011). Moreover, WNV  or JEV infections trigger
ell death processes by enhancing the expression of CCAAT/-
nhancer-binding protein homologous protein (CHOP) which is a
ranscription factor induced by the UPR (Medigeshi et al., 2007;
u et al., 2002). Although the effect of these ﬂaviviruses on differ-
nt UPR pathways has been unveiled, the role of TBEV infection
n cellular UPR is still unknown. The goal of our study was  to
nalyze the role of the UPR, in particular regarding the IRE1 path-
ay and ATF6 pathway in the course of TBEV infection. We ﬁrst
howed that TBEV infection enhanced Hsp72 protein expression
hich regulates and enhances the IRE1 pathway. We  then ana-
yzed that TBEV infection induced the IRE1 pathway, which resulted
n high expression of sXBP1. Moreover, we demonstrated that the
ranslocation and expression of the cleaved ATF6, which indicated
hat ATF6 pathway activation during TBEV infection. Finally, we
ound that 3,5-Dibromosalicylaldehyde (IRE1 inhibitor) and tau-
oursodeoxycholic acid (TUDCA), two inhibitors of the UPR, impair
BEV replication. These ﬁndings provide new insights into the
olecular mechanism of TBEV pathogenesis and may  offer a new
herapeutic approach to treat TBEV-induced diseases.
. Materials and methods
.1. Cell lines and virus strains
Vero E6 cells (ATCC CRL-1586) and A549 cells (ATTC CCL-185)
ere cultured in 24-well plates and maintained in Dulbecco’s mod-
ﬁed Eagle’s medium (DMEM) supplemented with 10% fetal calf
erum, 1% l-glutamine, 1% penicillin and 1% streptomycin. Both
ell types were incubated at 37 ◦C with 5% CO2. The propagation
f the TBEV strain K23 (GenBank accession no. AM600965) was
erformed in Vero E6 cells (Achazi et al., 2012). Viral titer was deter-
ined by plaque assay as described below. Unless stated otherwise,
n MOI  of 1 was used for the TBEV infection experiments.
.2. RNA extraction and RT-PCR
The total RNA was extracted from cells using QIAshred-
er/RNeasy RNA puriﬁcation columns (Qiagen, Hilden, Germany)
ollowing the manufacturer’s protocol. cDNA was  synthesized
rom 1 g of total RNA using Superscript II (Invitrogen, Karl-
ruhe, Germany) and random hexamer primers (Invitrogen).
CR was performed with the following primer pair: forward 178 (2013) 471– 477
primer TTACGAGAGAAAACTCATGGCC and reverse primer GGGTC-
CAAGTTGTCCAGAATGC (Samali et al., 2010). Glyceraldehyde
3-phosphate dehydrogenase (GAPDH) was used as a loading control
with the following primer pair: forward primer CCCATGTTCGT-
CATGGGTGT and reverse primer: TGGTCATGAGTCCTTCCACGATA
(Kurisaki et al., 2003). Cells treated with 1 g/mL of Tunicamycin
(TM) (Sigma–Aldrich, Munich, Germany) for 12 h were used as pos-
itive control. TM is an ER stress inducer which inhibits the N-linked
protein glycosylation. The products of ampliﬁcation were separated
by electrophoresis on a 3% agarose gel and visualized by ethidium
bromide staining. Images were photographed using the Chemidoc
system (Bio-Rad, Munich, Germany) and analyzed by the ImageJ
1.42 software.
2.3. ER stress inhibition experiments
To inhibit the ER stress response, the UPR inhibitors IRE1 and
TUDCA were used. The IRE1 inhibitor has the salicylaldehyde form
of the salicylaldimine and inhibits the IRE1 endoribonuclease activ-
ity speciﬁcally (Volkmann et al., 2011). TUDCA is a derivative
of an endogenous bile acid that alleviates ER stress (Berger and
Haller, 2011). Vero E6 cells were pre-treated for 1 h with 60 M
IRE1 inhibitor (Sigma–Aldrich) or 500 g/mL TUDCA (Calbiochem,
Darmstadt, Germany), respectively, and inoculated with TBEV for
another hour. Subsequently, cells were washed with PBS to remove
the unbound virus particles and were further incubated in the pres-
ence of the inhibitors. After 24 and 48 h post infection, respectively,
virus-containing cell culture supernatant was  analyzed by plaque
assay and viral protein from lysed cells was detected by western
blotting, respectively, as described below.
2.4. Plaque assay
Virus titers of cell culture supernatants were measured by
plaque assay. Brieﬂy, A549 cells were grown overnight in a 24-
well plate at 37 ◦C in 5% CO2. Serial dilutions of the cell culture
supernatant were added to the wells. After an incubation period of
1 h, carboxymethylcellulose (CMC) overlay medium (1.6% CMC  in
DMEM)  was added to each well. The plates were incubated under
the same conditions for four days. Each well was  ﬁxed by 3.7%
formaldehyde for 60 min  and stained with Naphthalene Black (1 g of
naphthol blue black, 13.6 g of sodium acetate, 60 mL  of glacial acetic
acid and up to 1 L of ddH2O). After 1 h, the Naphthalene Black was
decanted, the plaques were counted and the calculation of plaque-
forming units (PFU) was carried out according to Reed and Muench
(1938). Data were shown as PFU/mL.
2.5. Western blotting
Cells were washed twice with ice-cold PBS and lysed using
RIPA buffer (50 mM Tris-HCl, pH 8.0, 0.1% SDS, 1% NP40, 150 mM
NaCl, 20% glycerol, 2 mM dithiothreitol and 0.5% deoxycholate
acid). Nuclear proteins were harvested using the NE-PER nuclear
extraction kit (Thermo Scientiﬁc). Equivalent amounts of cellu-
lar lysates or nuclear proteins were electrophoretically separated
by 4–20% Tris-HEPES gels (Thermo Fisher Scientiﬁc, Schwerte,
Germany). After electrophoresis, proteins were transferred onto a
PVDF membrane by using a semi-dry blotter (Thermo Scientiﬁc).
Then membranes were incubated with blocking buffer (5% non-
fat milk in PBS solution with the detergent Tween 20) for 1 h and
subsequently incubated with primary antibodies (diluted 1:500
to1:1000) at 4 ◦C overnight. Anti-TBEV E protein antibody (MAB
1367) was used for detecting TBE virus (Niedrig et al., 1994). Anti-
actin and anti-PCNA (Proliferating cell nuclear antigen) antibody
was obtained from Cell Signaling Technology (Cell Signaling Tech-
nology, Frankfurt am Main, Germany). Anti-XBP1 was obtained
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rom Santa Cruz Biotechnology (Santa Cruz Biotechnology, Heidel-
erg, Germany). Anti-ATF6 was purchased from Abcam (Abcam,
ad Nauheim, Germany). After washing three times with PBS
olution with Tween 20, membranes were incubated with an
ppropriate peroxidase-conjugated secondary antibody for 1 h at
oom temperature (RT). Signal was developed using SuperSignal
est Dura Extended Duration Substrate (Thermo Scientiﬁc) and
etected by the Chemidoc system (Bio-Rad).
.6. Indirect immunoﬂuorescence microscopy
Vero E6 cells grown on glass coverslips were infected with TBEV
train K23. After 48 h, cells were ﬁxed with 3.7% formaldehyde
or 1 h and permeabilized with 0.1% Triton X-100. The coverslips
ere blocked with blocking buffer (5% bovine serum albumin [BSA]
n PBS) for 1 h and incubated with anti-Hsp72 (Enzo life science,
oerrach, Germany) in a 1:200 dilution. After incubation at RT
or 1 h, the coverslips were washed three times in PBS and then
reated with a goat anti-mouse secondary antibody conjugated
o tetramethyl rhodamine isothiocyanate (TRITC) (Dianova, Ham-
urg, Germany) at a dilution of 1:200. Nuclei were stained with
′,6-diamidino-2-phenylindole (DAPI). All samples were inspected
sing a ﬂuorescence microscope (Keyence), and images were ana-
yzed by ImageJ 1.42 software.
.7. Confocal immunoﬂuorescence microscopy
To generate an ATF6-expressing cell line, Vero E6 cells were
ransfected with a GFP-ATF6 plasmid using Fugene HD (Roche
iagnostics, Mannheim, Germany), following the manufacturer’s
nstructions. After transfection, cells were incubated with TBEV
train K23 for 24 h. TM (1 g/mL for 8 h)-treated cells were used
s positive controls. Cells were ﬁxed with 3.7% formaldehyde for
 h and permeabilized with 0.1% Triton X-100 at RT. Samples were
ncubated with the anti-TBEV E-protein antibody MAB  1367 (1:500)
s the ﬁrst antibody and an Alexa 594-labeled anti-mouse IgG anti-
ody (1:200) (Invitrogen) as the secondary antibody. Coverslips
ere mounted with ProLong Gold Antifade containing DAPI (Invi-
rogen), and cells were visualized by LSM780 confocal microscopy
Zeiss, Jena, Germany).
.8. Apoptosis detection assay
Vero E6 cells grown on glass coverslips overnight were infected
ith TBEV strain K23. After 48 h, samples were ﬁxed with 3.7%
ormaldehyde and properly washed with PBS. The apoptotic cells
ere detected using the TUNEL in situ Cell Death Detection Kit,
MR  red (Roche). As positive control, samples were incubated with
Nase I (3000 U/mL in 50 mM Tris-HCl, pH 7.5, 1 mg/mL  BSA) for
0 min  at RT.
.9. MTT  assay
Vero E6 cells were plated into 96-well culture dishes overnight.
fter removal of the cell culture medium, cells were incubated
n the absence (control) or presence of various concentrations of
UDCA or IRE1 inhibitor for 24 and 48 h. Medium was replaced with
0 L of 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
romide (MTT) (5 mg/mL) solution and was further incubated at
7 ◦C. After 4 h, the MTT  solution was removed and 200 L of DMSO
ere added and gently swirled. After the formazan crystals were
issolved, the optical density was measured at 570 nm using a spec-
rophotometer (Tecan Group Ltd., Maennedorf, Switzerland).178 (2013) 471– 477 473
2.10. Data analysis
Student’s t-test was  performed using Prism 5 software (Graph-
Pad, San Diego, Canada) to compare two sets of data. A p-value of
less than 0.05 was  considered statistically signiﬁcant.
3. Results
3.1. TBEV infection leads to induction of Hsp72 expression
Hsp72 protein is one of the newly identiﬁed components of
UPRosome which interacts with IRE1 and regulates IRE1 signaling
(Gupta et al., 2010). We  ﬁrst analyzed Hsp72 protein expres-
sion over the course of TBEV infection by immunoﬂuorescence.
As shown in Fig. 1A, Hsp72 protein expression was  persistently
increased during the course of infection compared to the control. It
is also known that Hsp72 gains its chaperone capacity to deal with
different stress situations by migrating to the nucleus (Knowlton
et al., 2000). Fig. 1B shows that Hsp72 protein was mostly accumu-
lated in the nucleus 48 h post infection. These results suggest that
Hsp72 might induce the IRE1 pathway during TBEV infection.
3.2. TBEV infection activates the IRE1 pathway
In the IRE1 pathway, active IRE1 truncates a 26-nucleotides
intron from the unspliced XBP1 (uXBP1) mRNA and generates a
cleaved form which encodes a highly active transcription factor,
sXBP1 (Yoshida et al., 2001). To detect whether TBEV infection acti-
vates the IRE1 pathway, XBP1 mRNA was by RT-PCR using speciﬁc
primer pairs. As expected, two forms of XBP1 mRNA were detected
in the infected cells after virus infection, and a similar result was
found in the TM-treated control cells (Fig. 2A). In contrast, sXBP1
could not be detected in untreated and uninfected cells. The induc-
tion of sXBP1 apparently increased in TBEV-infected cells at 24 h
post infection (Fig. 2B). Furthermore, the protein expression of
sXBP1 in the nuclear fractions was at a high level detected by west-
ern blotting (Fig. 2C). All together, these results indicate that IRE1
pathway activated during TBEV infection.
3.3. TBEV infection activates the ATF6 pathway
Next, we  investigated whether ATF6 was  activated in TBEV-
infected cells. During ATF6 activation, ATF6 translocates from the
ER to the Golgi apparatus where it is processed by site-1 proteases
(S1P) and site-2 proteases (S2P). The active fragment of ATF6 then
translocates to the nucleus (Haze et al., 1999). Cells transfected
with a GFP-ATF6 plasmid and infected with TBEV were used to test
this hypothesis by immunoﬂuorescence confocal microscopy. As
shown in Fig. 3A (panels a–d), GFP-ATF6 was  evenly distributed
in the cytoplasmatic ER-like structures and was not translocated to
the nucleus in uninfected control cells. However, this characteristic
distribution pattern changed after TBEV infection. In Fig. 3A (pan-
els i–l) the TBEV-infected cells show an intense ﬂuorescence near
the nucleus, thus indicating that ATF6 is activated by TBEV infec-
tion. The same results were found in the TM-treated control cells
in Fig. 3A (panels e–h). We then conﬁrmed these observations by
monitoring the cleavage of ATF6 expression in the course of TBEV
infection. Fig. 3B demonstrated that an induction of ATF6 cleavage
detected by western blotting. Taken together, these results show
that TBEV infection induces the ATF6 pathway.
3.4. Inhibition of UPR pathway decreases TBEV replicationAs the IRE1 pathway is activated by TBEV infection, we wanted
to determine whether this pathway was a host antiviral response or
facilitated virus replication. Therefore, we  tested the effect of the
474 C. Yu et al. / Virus Research 178 (2013) 471– 477
Fig. 1. Increased Hsp72 expression in TBEV-infected cells. (A) TBEV-infected Vero E6 cells were ﬁxed and stained with anti-Hsp72 antibody and DAPI, respectively, at 24 h
and  48 h post infection. Uninfected cells cultured for 48 h were used as control. Images show intracellular Hsp72 (red) and cell nuclei (blue) by indirect immunoﬂuorescence
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xpressed as mean ± SD of three independent experiments. *: P < 0.05.
RE1 inhibitor, a newly identiﬁed inhibitor of the IRE1 pathway,
n TBEV replication in TBEV-infected cells. In IRE1 inhibitor-
retreated cells the amount of infectious virus particles in the
ell culture supernatant was signiﬁcantly decreased compared to
he untreated cells at 24 h post infection (Fig. 4A). Also, western
lot analysis revealed that the level of TBEV E-protein expression
as reduced in the IRE1 inhibitor-treated cells (Fig. 4C). Interest-
ngly, the amount of infectious virus particles in the cell culture
upernatant was slightly increased at 48 h post infection (Fig. 4A)
lthough the level of TBEV-E protein still decreased. This discrep-
ncy suggested that the effect on inhibition of IRE1 pathway only
educed the ER protein folding capacity rather than hampering
irus assembly. Meanwhile, TBE virus may  utilize the other two
PR pathways to overcome or compensate this inhibition.
Because of these results we wanted to know whether the inhi-ition of upstream signaling of all three UPR pathways might limit
irus replication more efﬁciently. Therefore, we used the chemical
haperone and UPR inhibitor TUDCA. The inhibition assay was  per-
ormed as described in the methods section. We  observed a sharp ImageJ software in each panel was compared with the control panel. The data were
decrease of viral protein and infectious virus particles in TUDCA-
pretreated cells (Figs. 4B and D). In addition, MTT  assay was used
to rule out effects by pharmacological inhibition of ER stress on cell
viability (Fig. S2). Taken together, the results showed that inhibition
of IRE1 pathway, especially inhibition of all three UPR pathways,
decreased TBEV replication.
Supplementary material related to this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.virusres.2013.
10.012.
4. Discussion
Viruses have developed various strategies to exploit cellular
host responses for their beneﬁt and survival. In the whole cycle
of virus replication, virus activates ER stress by producing viral
double-stranded RNA intermediates and huge amounts of viral
proteins (He, 2006). Due to their positive-sense genomic RNA, it
is important for TBEV to use intracellular membranes to create
a suitable microenvironment for replication. After viral particles
C. Yu et al. / Virus Research 
Fig. 2. Induction of spliced XBP1 expression during TBEV infection. (A) XBP1 mRNA
was  measured by RT-PCR. Vero E6 cells were either infected with TBEV strain K23
or  treated with TM (1 g/mL). XBP1 mRNA was ampliﬁed by RT-PCR using XBP1-
speciﬁc primers. The products were separated by electrophoresis in 3% agarose gels
and  DNA was visualized by ethidium bromide. The unspliced XBP1 (uXBP1) mRNA
was  observed as a 289-bp band, and spliced XBP1 (sXBP1) mRNA was  observed
as  a 263-bp band. TM was  used as a positive control for the induction of sXBP1.
GAPDH mRNA was used as loading control. The representative image was  shown.
(B) The band intensities of sXBP1 mRNA were measured by ImageJ software and
expressed as fold increase compared to control (Ctrl 0 h). *: P < 0.05. (C) Western
blotting analysis of the spliced XBP1 expression. Nuclear extract were harvested at
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vhe  indicated times post infection and analyzed by western blotting using an XBP1
ntibody. TM treated cells were used as a positive control. The PCNA was  used as a
uclear loading control. One of two representative results was  shown.
ind to the cell surface, the viral RNA genomes are released into
he cytoplasm and used for protein translation (Mandl, 2005). The
rocess of TBEV assembly is detected by electron microscopy in
he lumen of the ER and highly associated with cellular ER mem-
rane rearrangements (Overby et al., 2010; Ruzek et al., 2009).
everal ﬂaviviruses including WNV, DENV and JEV can activate
nd regulate the UPR, a cellular stress response to alleviate ER
tress caused by the accumulation of viral proteins; however, noth-
ng is known about the regulation of the UPR in TBEV infection
Ambrose and Mackenzie, 2011; Klomporn et al., 2011; Wu et al.,
011).
In this study, we report for the ﬁrst time that TBEV triggers
he IRE1 pathway of the UPR, as the expression of spliced XBP1
RNA and protein increased in TBEV-infected Vero E6 cells (Fig. 2A
nd C). Similar results were also observed in the course of JEV
nd DENV infections (Yu et al., 2006). In contrast, hepatitis C virus
eplicons inhibit the transactivation of XBP1, demonstrating the
arious pathogenic mechanisms of different ﬂaviviruses (Tardif178 (2013) 471– 477 475
et al., 2004). IRE1 pathway activation is downstream of ATF6 acti-
vation, and cleavage of ATF6 has been shown to up-regulate the
level of XBP1 mRNA (Lee et al., 2002). The cleaved ATF6 moves
from the ER to the Golgi complex and translocates to the nucleus.
We  demonstrated that activated ATF6 was accumulated near the
nucleus of TBEV-infected cells (Fig. 3A). We then further conﬁrmed
the expression of cleaved ATF6 by western blotting which suggests
that TBEV modulate the activation of the ATF6 pathway at the same
time (Fig. 3B).
The UPR is initiated to restore normal ER homeostasis during
ER stress. Cell death occurs if the balance cannot be sustained (He,
2006). Activation of the IRE1 pathway may  enhance the protein-
folding ability which alleviates ER stress and reduces cytopathic
effects during JEV and DV infection (Yu et al., 2006). In our exper-
iments, we  could not ﬁnd apoptotic cells associated with TBEV
infection (Fig. S1). Thus, activation of the IRE1 pathway by TBEV
could also be a mechanism to avoid cell death due to virus infec-
tion. Moreover, Hsp72, which is known to protect cells from ER
stress (Gupta et al., 2010), is highly expressed in TBEV-infected
cells (Fig. 1B). We  also noticed nuclear accumulation of Hsp72 in
TBEV-infected cells (Fig. 1A). This accumulation strengthens the
resistance of cells to cellular death (Knowlton et al., 2000). Besides,
it was shown for a close relative of TBEV, the hepatitis C virus,
that overexpression of Hsp72 enhances viral RNA replication by
increasing levels of the replicase complex (Chen et al., 2010). Taken
together, we provide evidence that Hsp72 expression and XBP1
activation by TBEV may  alleviate UPR which sustains the homeo-
stasis against cell death and facilitates virus replication.
Supplementary material related to this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.virusres.2013.
10.012.
Because spliced XBP1 is a transcription factor regulating genes
responsible for enhancing the protein-folding ability and facili-
tating the degradation of misfolded protein in the ER, the IRE1
pathway provides an adaptive capacity against ER stress (Lee et al.,
2003). We  postulated that the IRE1 pathway induced by TBEV
supports the cells in handling the ER stress and allows the virus to
replicate more efﬁciently. This would mean inhibition of the UPR
would decrease viral replication. Our results show that inhibition
of the IRE1 pathway as well as inhibition of all three UPR pathways
by IRE1 inhibitor or TUDCA, respectively, caused a reduction in
viral titers. As the virus reduction in the TUDCA-treated cells was
higher than that in the IRE1 inhibitor-treated cells, more than one
UPR-signaling pathway might be involved in TBEV replication.
Although the exact mechanisms of host and virus involved in XBP1
splicing and UPR activation have to be further investigated, we
show here that TBEV initiated the IRE1 pathway and beneﬁted
from the cellular UPR. For this reason, inhibition of the UPR might
be a novel option for a therapeutic treatment of TBE.
Recent observations have shown that UPR initiates the inﬂam-
mation response and regulates cytokine release (Zhang and
Kaufman, 2008). TBEV invades the central nervous system by
crossing the blood–brain barrier and then causes neural inﬂam-
mation by its replication (Dumpis et al., 1999). However, TBEV
rearranges intracellular membrane compartments and delays the
release of inﬂammation cytokines which facilitate the virus entry
into the central nervous system (Overby et al., 2010). UPR-induced
inﬂammation-assisted or -restricted disease progression relies on
many factors such as the cell type, disease stage and type of ER sen-
sors (Garg et al., 2012). Further studies in neural cells and mouse
models with TBEV infection have to be performed to investigate
the role of UPR-mediated inﬂammation in pathogenesis. Moreover,
most TBE cases occur through a tick bite which delivers viruses into
the host’s circulation system. Dendritic cells are one of the most
important cellular components which present antigen and initiate
the adaptive immune response during virus invasion (Robertson
476 C. Yu et al. / Virus Research 178 (2013) 471– 477
Fig. 3. Analysis of ATF6 pathway during TBEV infection. (A) Relocation of GFP-ATF6 during TBEV infection. GFP-ATF6 plasmids were transiently transfected into Vero E6 cells
for  24 h. Then the cells were infected with TBEV strain K23 and further cultured for 24 h (panels i–l) or treated with TM (panels e–h) for 8 h. Untreated and uninfected cells
were  used as controls (panels a–d). Confocal microscopy was used to detect GFP-ATF6 (green), TBEV E protein (red) and cell nuclei (blue). Bar chart: 10 m.  (B) The expression
of  ATF6 cleavage from nucleus after TBEV infection was analyzed by western blotting. TM treated cells were used as a positive control for producing ATF6 cleavage. The PCNA
was  used as a nuclear loading control. One of two  representative results was shown.
Fig. 4. Effects of UPR inhibitors on the TBEV replication. Vero E6 cells were treated with IRE1 inhibitor (60 M) or TUDCA (500 g/mL) for 1 h and then infected with TBEV.
(A  and B) In the supernatant, virus titers were measured by plaque assay at 24 h and 48 h. The data represent the mean ± SD of three independent experiments. (C and D)
Intracellular viral proteins were analyzed by western blot, and representative images were shown at 24 h and 48 h post infection. The virus titers with and without drug
treatment at the indicated times were compared with Student’s t test. **: P < 0.01; ***: P < 0.001.
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t al., 2009). However, MHC  class I molecules displayed on the cell
urface of dendritic cells are impaired by the ER stress response
Granados et al., 2009; Ulianich et al., 2011). This phenomenon
aused by ER stress response may  be harmful for the dendritic
ells presenting viral antigens and inhibit the host’s antiviral
esponse.
In conclusion, our report provides the ﬁrst evidence that TBEV
nfection activates the IRE1 pathway and ATF6 pathway of the UPR
nd strongly up-regulates the expression of Hsp72. Furthermore,
harmacological treatment of the UPR pathway has decreased TBEV
eplication which might suggest a new route of antiviral therapy.
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